The study on the efficacy of oral analgesics reported that no single class of drug is effective in post-surgical dental pain. Pain following removal of third molar is most commonly used and widely accepted acute pain model for assessing the analgesic effect of drugs in humans. Reports demonstrated that analgesic efficacy in the human dental model is highly predictive. The high incidence of false-negative findings in analgesic investigations hinders the process of molecular discovery. Molecular mechanism of post-surgical pain is not known. More importantly, the animal model for postoperative dental pain is not well established. In an attempt to discover an effective post-surgical dental pain blocker with acceptable side effects, it is essential to elucidate the molecular mechanism of post-operative dental pain. The present study investigated mandibular molars extraction in rat as an animal model for the post-operative dental pain in central nervous system. Using c-Fos immunohistochemistry, we demonstrated that pre administration of GBP (150 mg/kg. i.p) significantly (p< 0.01) neutralized the surgical molar extraction induced c-Fos expression bilaterally in rat hypothalamus. Present results indicate that pain after surgical molar extraction might follow novel neural pathways therefore difficult to treat with existing anti-nociceptive drugs.
Introduction
Pain after dental surgery still an unsolved issue and also an important factor in quality of life of patients at postsurgical periods. Surgery induces surgical stress and pain. This may result postoperatively morbidity and mortality. Surveys demonstrated that about 50-70% of patients experience moderate to severe pain after surgery indicating that despite the development of new drugs and improved analgesic techniques, postoperative pain remains still underevaluated and poorly treated. One important reason is the pathophysiology of postoperative pain still not known. To overcome clinical pain states, a mechanism based therapy may improve its management. Therefore it is now vital to reveal the molecular mechanism of postoperative pain. Surgery induced secondary hyperalgesia occurs in undamaged tissue adjacent to an injury responsible to develop secondary hyperalgesia and has been shown to depend only on Central sensitization.
Thus, once neuronal alterations that fully developed due to secondary hyperalgesia, their reversal by systemic administration of analgesic mostly difficult (1) . Study in relative efficacy of oral analgesics reported that no single class of drug is effective in post-surgical dental pain. Moreover, there is association with gastrointestinal, cardiovascular and renal adverse effects and opioid is life threatening. Publication bias inflated the real picture of the efficacy of oral analgesics study in third molar extraction model. Studies reported that positive findings tend to be published more frequently than studies that report negative findings. 97% of the acute pain investigations study that yielded positive results clearly showed overestimation (3) .
Reports on High incidence of false-negative findings in analgesic investigations mislead the process to reveal the molecular discovery of post-surgical dental pain mechanism. More importantly, less attention has been focused on the development of post-operative dental pain model and to understand the mechanism of postoperative acute dental Pain. Molecular mechanism of post-surgical dental pain is not known. Therefore, clinical results of the analgesics efficacy observed in human 3rd molar extraction model remains difficult to translate in molecular level. More importantly, the animal model for postoperative dental pain is not well established or difficult to generate (3) .
In an attempt to discover an effective post surgical dental pain blocker with acceptable side effects, It is now essential to elucidate the molecular mechanism of postoperative dental pain.
Pain after dental surgery still remains an important factor in quality of life of patients at the early postoperative periods. Extraction of third molars activates peripheral as well as central pain pathways (4-7). Study in relative efficacy of oral analgesics reported that no single class of drug is effective in post-surgical dental pain. Moreover, there is association with gastrointestinal, cardiovascular and renal adverse effects and opioid is life threatening (3) . Pain following removal of third molar model, a clinical research tool of postsurgical pain has been in widespread use for over 50 years, is well characterized, and is frequently used to investigate the efficacy of novel analgesic compounds (3) .
Surgical characteristics of the third molar surgery allow subjects to experience moderate to severe postoperative pain (3) .
In 1996 Brennan et. Al., in rat post-operative pain models (8) and in 2002 Kawamata et. Al., in Human volunteer models (2) reported that mechanisms of pain behavior following an incision are different from mechanisms described for inflammation, neurogenic, or neuropathic etiologics. Kazi et. al. (9) , in a post-incisional rat model (20) , demonstrated that paraventricular nucleus of the hypothalamus might be the neuromodulatory area in post-surgical pain (9) .
Gabapentin (neurontin) a structural analogue of GABA has proven to be effective in reducing both postoperative and chronic pain, hyperalgesia, and allodynia in a wide range of animal models (10) . GBP is well tolerated and shows very favorable side effects profile: lack of drug interaction and lack of potential for causing drug dependence (10) . Reports suggest that gabapentin may exert its analgesic effect at both the spinal and supraspinal levels. The antihyperalgesic effect of gabapentin does not involve opiate pathways (11) . Chronic administration does not lead to tolerance and morphine tolerance does not affect gabapentin effect on pain. GBP reduced the need for opioids in post-operative treatment, blocks and reverse the antinociceptive opioids tolerance and also prevent opiate withdrawal symptoms (11) .
GBP has been reported as an anxiolytic drug in previous studies (11) Recently, several reports have indicated that GBP may indeed have a place in the treatment of postoperative pain (12) . However, the exact molecular mechanism of action of GBP to block postoperative pain and stress is being investigated (9) . GBP is able to block Ca 2+ and Na++ channels and open K channels thereby inhibiting the hyper-excitability of sensory neurons, thus ameliorating pain. GBP decreased the number of action potentials during depolarization in neuropathic pain. More importantly, the cellular and neuroanatomical functional target sites of GBP to block post-operative pain and stress is not known (12) .
The immediate early genes (IEGs) encoded protein c-Fos is considered to be a transcription factor. c-Fos is expressed at low or undetectable levels in most cell types, but can be rapidly and transiently induced by many types of stimuli, including tissue trauma. Monitoring the nuclear expression of c-Fos, the protein product of the c-fos gene, is an established reliable anatomical technique for the functional mapping of the neuronal activity and can be helpful to examine the ability of neurons to react with changes in gene expression to external stimulation under physiological and pathological conditions (13) (14) (15) . In this study, we used extraction of molars in the rats as a comparable model (8, 9) to study the GBP regulated neuromodulatory effects and its sites in post surgical dental pain process and also to compare with previously published results on post-incisional pain model (9) .
Material and Methods
We obtained approval from the Institutional Animal Care and Use Committee for this study. All experimental procedures were carried out in accordance with CARE Universiti Teknologi MARA (UiTM), guidelines.
Male Sprague−Dawley rats (180−200 g), Animals were housed in groups of two, and had free access to food and water at all times. Animals were on a fixed 12 h light− dark cycle. In order to minimize stress, all animals were brought to the laboratory and acclimatized once daily for at least five days by exposure to the general handling and anaesthesia procedures.
Surgical Procedures
The surgical procedure was based on that described previously (9) . Briefly, rats were anaesthetized with intraperitoneal injection of sodium pentobarbital (50 mg/ kg). Lower 1st and 2nd molars of either side were surgically extracted. Sham extraction (intact) was performed by opening of the mouth for 5 min. intact rats received no gabapentin treatment. Gentle pressure with surgical cotton was applied for hemostasis.
Application of Gabapentin in the Experimental and Control Groups
GBP was parched from Sigma and dissolved in 0.9% saline. Six rats per group were used in all experiments Control: Intact (no extraction, only received i.p., injection of normal saline. The mouth was kept open for 5 min. 2. Molar extraction: mandibular 1st and 2nd molars of either side were surgically extracted. Gentle pressure with surgical cotton was applied for hemostasis. 3. Molar Extraction plus GBP administration: A single intraperitoneal injection (i.p.) of GBP (150 mg/kg) dissolve in 0.9% saline was given 20 minutes before tooth extraction. In all cases the dosing volume was 1 mL. Rats of all groups were kept under deep anesthesia until sacrifice to minimize the pain perception.
Perfusion and Tissue Collection
At 90 minutes after tooth extraction the deeply anesthetized rats were perfused transcardially with heparinized physiological saline, followed by 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4. The brains were cryoprotected. Serial 40 μm thick sections were cut with a freezing microtome.
Immunohistochemistry
The immunocytochemical detection of c-Fos protein was performed using the peroxidase-antiperoxidase (PAP) detection protocol (9) . Free-floating sections were then incubated at 4° with rabbit antibody to c-Fos protein (Santa Cruz Biotechnology Inc., Santa Cruz, CA) diluted 1:4,000. Then incubated in a 1:2,000 dilution of goat anti-rabbit IgG (E-Y Laboratories Inc., San Mateo, CA) at 4° and followed by the tertiary antibody, peroxidase-antiperoxidase (PAP) in a 1: 2,000 dilution at 4°. The primary, secondary and tertiary antibodies were diluted to appropriate concentrations in 0.3% bovine serum albumin and 1% normal goat serum and 0.05% sodium azide. The DAB method for visualization of peroxidase was used (9) . After the final rinses the sections were mounted onto gelatin-chrome alum-coated glass slides, air-dried, dehydrated with ethanol, cleared in xylene, and coverslipped. The specificity of the immune reaction was assessed by omitting the primary antibody in which no specific immunostaining was detected.
The sections were analyzed under a microscope and the labeled c-Fos positive neurons per section were counted. Counts were obtained from a 1 in 2 series of sections and 6 sections per animal were used. Then, the mean number of c-Fos positive neurons (± standard deviation: S. D.) for each time point was calculated. The statistical analysis was performed using a paired t test and differences at p<0.001 were considered significant.
Results

PVN of the Hypothalamus
Molar Extraction: In this study at 90 minutes after the surgical tooth extraction, a robust increase in Fos expression was found bilaterally in the PVN of the hypothalamus (9) .
As shown in Figure 1 , compare to intact the higher numbers of densely labelled c-Fos positive neurons were observed bilaterally in the PVN at 90 minutes after surgical tooth extraction. The semi-quantitative analysis of the Molar Extraction plus GBP administration: As shown in Figure 2 , Fos positive cells induced by surgical tooth extraction ( Fig. 2A) in the PVN were significantly suppressed when rats were pre-treated with the administration of GBP (150 mg/kg, i.p.) 20 minutes prior to paw surgery ( Fig. 2A and 2B ). In the PVN at 90 minutes after surgical tooth extraction the number of c-Fos immunoreactive cell bodies was 98 ± 3 in the intact and 20 ± 2.9 in the GBP pretreated rats per section (p<0.001) (Fig. 2B) . These results suggested the neutralizing effect of GBP pre-treatment on molar extraction induced activation of PVN.
Spinal Trigeminal Nucleus
Molar Extraction: As shown in Figure 3 , surgical tooth extraction showed significant increase in the number of c-Fos immunostained neurons in the spinal trigeminal nucleus as compared to intact rats (Fig. 3A, intact and Fig. 3B, GBP treated) . This finding is consistent with the previously published report (10) .
Molar Extraction plus GBP administration: As shown in Figure 3 C rats pre-treated with GBP (150 mg/kg, i.p.) 20 minutes before surgical tooth extraction did not neutralize the surgical tooth extraction induced increased in c-Fos expression in the spinal trigeminal nucleus. Figure 3C , shows semi-quantitative analysis of the number of c-Fos protein-like immunoreactive nerve cell bodies in the spinal trigeminal nucleus in intact, after surgical tooth extraction and after administration (i.p.) of GBP (150 mg/kg, i.p.) 20 minutes before molar extraction. The number of the c-Fos positive neurons was 3 ± 0 in the intact, 19 ± 2 in the surgical tooth extraction and 18 ± 1 in the GBP treated rats per section (p<0.001).
Discussion
The result of this study demonstrated that the surgical tooth extraction induced increase in c-Fos expression in the paraventicular nucleus of the hypothalamus was attenuated by a single dose (150 mg/kg, i.p.) of GBP given 20 min. before surgical tooth extraction. In addition, GBP pretreatment did not attenuate the tooth extraction induced elevated c-Fos like immunoreactivity in the spinal trigeminal nucleus. To our knowledge, the present study demonstrated for the first time the neuromodulatory functional sites of GBP in post-surgical tooth extraction.
Gabapentin (Neurontin) a structural analogue of GABA has proven to be effective in reducing pain, hyperalgesia, and allodynia in a wide range of animal models including postoperative pain (10) and anxiety (17) . A recent report demonstrated that gabapentin administered was associated with a significant reduction in the requirement for regional analgesia (epidural analgesia) there were also significant improvements in postoperative pain scores and patient satisfaction with less postoperative motor block (17) . GBP binds to the α2δ subunit of calcium channels, a subunit ubiquitous to all voltage-dependent calcium channels (VDCCs). Report demonstrated that preoperative GBP decreased anxiety and improved early functional recovery from knee surgery (17) . The present study demonstrated that c-Fos like immunoreactive neurons were significantly increased in the PVN of the hypothalamus. This increase in c-Fos expression in PVN was attenuated by the administration of GBP (150 mg/kg, i.p.) 20 minutes prior to molar extraction. This study indicate that pre administration of GBP antagonize the surgical molar extraction induced activation of the PVN. This result is in accordance with our previous report on rat incisional pain model (9) . Several lines of evidence suggest that the hypothalamus is involved in trigeminal pain processing (18) .
However, further studies are needed to explain the underlying mechanisms of the GBP induced attenuation of c-Fos in the PVN after surgical molar extraction.
Fos dimerize with Jun family and form transcription factor called activator protein-1 (AP-1). AP-1 complexes interact with a consensus sequence TGACTCA in the regulatory regions of target genes and stimulate or repress transcription of the target genes thereby subserving long-term changes in cellular function. c-Fos induction happened at least 5 regulatory signal transduction pathways. Therefore in our study, extraction induced induction and then GBP induced inhibition of c-Fos protein in the PVN of the molar extracted rats indicated the GBP regulated unknown gene expression occurred in the PVN through an unknown circuit (15) Present study also demonstrated that GBP administration 20 minutes before surgical molar extraction didn't not attenuated the extraction induced c-Fos like immunoreactive neurons in the spinal trigeminal nucleus. c-fos gene contains several cis-acting elements, that could confer variety of trans-synaptic signals via interdependent signal transduction pathways (e.g., PKA, PKC, CAM kinase and MAP kinase e.t.c.). However it is noteworthy to mention that, c-Fos induction does not provide evidence for the activated specific target genes in the certain cell type of interest. Therefore, further study is required to reveal this unknown gene involved in the c-Fos activated neurons. The results of this study strongly indicated that, to neutralize the molar extraction induced activation of PVN an unknown factors (gene) in the c-Fos activated neurons in the spinal trigeminal nucleus played a crucial role. Therefore, to reveal molar extraction induced novel neuronal circuit further study is essential to identify the gene (s) in c-Fos induced neurons in the PVN and in the spinal trigeminal nucleus. Since c-Fos protein has extralong half lives, we therefore speculated that neurons in the spinal trigeminal nucleus remain active in order to maintain the expression of the unknown target genes through an unknown circuit to attenuate c-Fos expression in the PVN (15) .
In this regards, a recent report showed that gabapentin inhibited substance P facilitated release of the sensory neurotransmitter glutamate in an in vitro preparation of the spinal trigeminal nucleus of the rat (19) . Another recent report observed the existence of bilateral descending hypothalamic projections to the spinal trigeminal nucleus (20) , Moreover, studies reported that a substantial number of spinal trigeminal nucleus neurons directly send their axons to hypothalamic regions (21) . Report demonstrated that substance P receptor like immunoreactivity (SPR-LI) neurons projected to paraventricular hypothalamic nucleus. The hypothalamus a key player in nociceptive processing and modulated the perception of trigeminal pain (20, 21) . Tooth pulp stimulation showed strongest effect in the hypothalamus, significantly up-regulated mRNA levels for the neuropeptides: galanin (GAL), vasopressin (AVP), oxytocin (OT), substance P (SP), vasoactive intestinal peptide (VIP), endomorphin-2 (EM-2), and opioid receptors: MOR, DOR and KOR (22) . Oxytocin OX When centrally applied and vasopressin (VP), either centrally applied or microinjected into the spinal trigeminal nucleus (23) , reduced the amplitude of trigeminal reflex induced by noxious tooth pulp stimulation. OX when systemically applied attenuated electrical whisker pad stimulation-induced pain-vocalization in newborn rats. Oxytocin-induced analgesia in mice and vasopressininduced analgesia in rat are mediated by the vasopressin-1A receptor (V1aR), V1aR mRNA was detected in many brain areas, including the spinal nucleus of the trigeminal tract (23) . Another report demonstrated that this OX mechanism of pain modulation only involved opiate pathway (24) . More importantly, antinocipeptive effect of gabapentin does not involve opiate pathways (10, 11) . However, the effect of GBP on vasopressin (VP) and oxytocin (OX) regulation not known, GBP might exert its effect on VP and OX trans-synaptically (21) . It cannot be ruled out that GBP might have exerted its effect on VP and OX trans-synaptically (24) through an unknown non-opioid circuit or GBP might have neuromodulated novel signaling molecules of pain regulating circuit without involving opiate pathways (19) . Further study is warranted to reveal the neurochemistry of the molar extraction induced c-Fos containing neurons.
Thus, our present study suggests that GBP might differentially modulate c-Fos expression in surgical tooth extraction in the PVN and in spinal trigeminal nucleus (21, 25) . We therefore speculated that the increased in c-Fos expression observed in our study at spinal trigeminal nucleus which was not attenuated by gabapentin preadministration indicated the trans-synaptic functional activation of gabapentin on spinal antinoception system (21, 22, 25) . Analyzing the above reports the results of this study speculate the existence of novel bi-directional neuromodulatory circuit between hypothalamus and spinal trigeminal nucleus involved in the regulation of surgical molar extraction. Therefore, further study is needed to reveal the nature of this GBP regulated c-Fos like immunoreactive neurons in the PVN and the spinal trigeminal nucleus observed in present study. Present result also indicates that pain after surgical molar extraction might follow novel bi-directional neuromodulatory pathways therefore difficult to treat with existing antinociceptive (21, 22) .
The results obtained here will to be useful for further studies to gain more insights into the mechanisms underlying the antinociceptive and anxiolytic actions of after dental surgery.
These results also are consistent with our previous published report on rat incisional model (9) . Therefore, this study proposes that tooth extraction in rat validate as an experimental animal model for post-surgical dental pain study.
As it has been proved that, number of different challenges involved through multiple signal transduction pathways in the induction c-Fos expression (23) . Finally, our present findings indicate that GBP may differentially modulate c-Fos expression in surgical molar extraction (antagonising the PVN activity whereas stimulating the spinal trigeminal system) and also provide some clue to investigate whether GBP exert its action simultaneously through multiple separate pathways in neuromodulation (9, 16, 22, 23) after surgical tooth extraction. This study furthers our understanding of the mechanism of acute post-surgical dental pain.
Resumo
O estudo da eficácia relativa dos analgésicos orais relatou que nenhuma classe única de fármaco é eficaz na dor pós-cirúrgica dental. A dor após a remoção do terceiro molar é o modelo de dor aguda mais comumente usado e amplamente aceito para avaliar o efeito analgésico de drogas em seres humanos. Os relatos demonstraram que a eficácia analgésica no modelo dental humano é altamente preditiva. A alta incidência de achados falso-negativos em investigações analgésicas dificulta o processo de descoberta molecular. O mecanismo molecular da dor pós-cirúrgica não é conhecido. Mais importante ainda, o modelo animal para a dor pós-operatória não está bem estabelecido. Numa tentativa de descobrir um bloqueador de dor dental pós-cirúrgico eficaz com efeitos secundários aceitáveis, é essencial elucidar o mecanismo molecular da dor pós-operatória dental. Neste estudo investigamos a extração de molares inferiores de ratos como modelo animal para a dor pós-operatória no sistema nervoso central. Utilizando análise imunohistoquímica de c-Fos, demonstrou-se que a administração prévia de GBP (150 mg/kg i.p) significativamente (p<0,01) neutralizou a expressão c-Fos induzida por extração molar cirúrgica bilateralmente no hipotálamo de rato. Os resultados indicam que a dor após a extração molar cirúrgica pode
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seguir novas vias neurais, portanto, difícil tratar com as drogas antinociceptivas existentes.
